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between adjusted and unadjusted groups, particularly inKriesche et al referred to a retrospective analysis of
the 34 BMI category, would help the readers to better51,927 renal transplants registered in United States Re-
understand the ramifications of this finding.nal Data System (USRDS). Our data were drawn from
Figure 3 in the paper of Lowrie, Ofsthun, and Lazarusa single center experience on quite a smaller number of
[1] supports the statement that small and underweightpatients. Only one of our patients had a body mass index
patients are susceptible to underdialysis. However, it(BMI) higher than 36 kg/m2, which according to Meier-
should be noted that given the current practice of hemo-Kriesche, has the highest risk of graft failure. After 14
dialysis in the United States, it would be uncommon toyears, the allograft of this patient is still functioning with
find a small or underweight patient receiving lower dosea serum creatinine was 2.0 mg/dL. We considered an-
of dialysis; for instance, the frequency of underweightother 14 patients with BMI higher than 30 kg/m2. Their
patients with a standard prescription Kt/V of 1.2 wasgraft survival probability at 15 years was 92.8%, their
1% in a recent study [3]. When standard prescriptionmedian serum creatinine at the last visit was 1.4 mg/dL
of hemodialysis is applied, dialysis dose, as expressed as(0.9 to 2.9 mg/dL), by excluding the only patient who
Kt/V or urea reduction ratio (URR), is predictably higherreturned to dialysis.
in small and underweight patients than normal or over-On the other hand, Meier-Kriesche et al interpreted
weight patients. Thus, it is more common to see under-with caution their own data. They pointed out that it
weight patients receiving more dialysis than overweightwas difficult to ascertain whether the poor death-censored
and obese patients [3]. Despite this information, under-graft survival in obese patients was attributable to neph-
weight patients have a higher mortality, and conversely,ron underdosing or whether it was an obesity-related
despite underdialysis, overweight patients tend to havecomorbidity jeopardizing the graft, such as obesity and
a better survival [3]. The point is that once the patienthypertension. Moreover, they found that also a low BMI
receives a certain amount of dialysis, the survival is lessincreased the risk of late failure. It is difficult to advocate
dependent on dialysis dose delivered per treatment, butany role for an insufficient nephron mass in the latter
more to factors such as nutrition and comorbid condi-patients.
tions.Although the potential role of nephron underdosing
Thus, the extremely low Kt that is used by Lowrie,in chronic allograft nephropathy (CAN) is intellectually
Ofsthun, and Lazarus in underweight patients to demon-attractive and worth of further investigation, we think
strate the deleterious effect of underdialysis in such pa-that the risk of glomerular hyperfiltration caused by an
tients is outside the range obtained in regular clinicalinadequate nephron mass of the donor is overwhelmed
practice. Therefore, we are concerned that the reportedby many other more relevant risk factors.
results of the statistical analysis may be based on extrapo-
lation outside the plausible data with a few cases thatClaudio Ponticelli and Margarita Villa
Milan, Italy may exhibit undue influence on the regression. We think
